{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:24:13Z","timestamp":1789133053431,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HC19C0028"],"award-info":[{"award-number":["HC19C0028"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2022-0170"],"award-info":[{"award-number":["6-2022-0170"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2020-0202"],"award-info":[{"award-number":["6-2020-0202"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2022-0047"],"award-info":[{"award-number":["6-2022-0047"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.atherosclerosis.2023.03.014","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T20:08:44Z","timestamp":1679342924000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Differential association between apolipoprotein B and LDL cholesterol and cerebral atherosclerosis according to pre-stroke statin use"],"prefix":"10.1016","volume":"371","author":[{"given":"Minyoul","family":"Baik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Suk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoe","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-2616","authenticated-orcid":false,"given":"Young Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.03.014_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.03.014_bib2","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.03.014_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3904\/kjim.2019.188","article-title":"2018 Guidelines for the management of dyslipidemia","volume":"34","author":"Rhee","year":"2019","journal-title":"Korean J. Intern. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.03.014_bib4","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.03.014_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4065\/mcp.2009.0517","article-title":"Using apolipoprotein B to manage dyslipidemic patients: time for a change?","volume":"85","author":"Harper","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.03.014_bib6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2017.06.015","article-title":"Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Wong","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2023.03.014_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low\u2010density lipoprotein cholesterol and non\u2013high\u2010density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.03.014_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacl.2007.12.006","article-title":"Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice","volume":"2","author":"Sniderman","year":"2008","journal-title":"J. Clin. Lipidol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2023.03.014_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","article-title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.03.014_bib10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen Camilla Ditlev","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2023.03.014_bib11","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","article-title":"Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment","volume":"117","author":"Kastelein","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.03.014_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000759","article-title":"Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials","volume":"3","author":"Thanassoulis","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.03.014_bib13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non\u2013HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.03.014_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.03.014_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000047697","article-title":"Yonsei stroke registry","volume":"12","author":"Lee","year":"2001","journal-title":"Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.03.014_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3349\/ymj.2010.51.3.318","article-title":"Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients","volume":"51","author":"Kim","year":"2010","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.03.014_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J. Cardiovasc. Risk"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.03.014_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk, Circulation","volume":"4","author":"Sniderman","year":"2011","journal-title":"Cardiovascular quality and outcomes"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.03.014_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.101.5.477","article-title":"Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS)","volume":"101","author":"Gotto","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.03.014_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2005.12.013","article-title":"Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II","volume":"151","author":"Ballantyne","year":"2006","journal-title":"Am. Heart J."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.03.014_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.121.057807","article-title":"Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab","volume":"146","author":"Hagstr\u00f6m","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.03.014_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejvs.2016.05.014","article-title":"Risk of recurrent stroke in patients with symptomatic mild (20-49% NASCET) carotid artery stenosis","volume":"52","author":"Karlsson","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.03.014_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2020.1326","article-title":"Prognosis of asymptomatic intracranial stenosis in patients with transient ischemic attack and minor stroke","volume":"77","author":"Hurford","year":"2020","journal-title":"JAMA Neurol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2023.03.014_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.114.011147","article-title":"Cause and mechanisms of intracranial atherosclerosis","volume":"130","author":"Ritz","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.03.014_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archneur.1991.00530190033011","article-title":"Predictors of intracranial carotid artery atherosclerosis: duration of cigarette smoking and hypertension are more powerful than serum lipid levels","volume":"48","author":"Ingall","year":"1991","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.03.014_bib26","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/STROKEAHA.111.620104","article-title":"High levels of apolipoprotein B\/AI ratio are associated with intracranial atherosclerotic stenosis","volume":"42","author":"Park","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.03.014_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.03.014_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2023.03.014_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.119.041998","article-title":"Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes","volume":"140","author":"Marston","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.03.014_bib30","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1038\/s41598-018-24157-w","article-title":"Association between fasting triglyceride levels and the prevalence of asymptomatic intracranial arterial stenosis in a Chinese community-based study","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2023.03.014_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00276","article-title":"Association of carotid atherosclerosis with lipid components in asymptomatic low-income Chinese: a population-based cross-sectional study","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.03.014_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2020-325630","article-title":"Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review","volume":"92","author":"Leng","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:51:29Z","timestamp":1777409489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"alternative-id":["S0021915023001168"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential association between apolipoprotein B and LDL cholesterol and cerebral atherosclerosis according to pre-stroke statin use","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}